• Campusvej 55

    5230 Odense M

    Denmark

1982 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1982 2019

Filter
Conference abstract for conference
2017

Differential intrathecal inflammatory markers in acute optic neuritis and later conversion to multiple sclerosis

Olesen, M. N., Soelberg, K., Nilsson, A. C., Jarius, S., Madsen, J. S., Grauslund, J., Smith, T. J., Lillevang, S. T., Brandslund, I., Paul, F., Weinshenker, B. G. & Asgari, N., 2017. 1 p.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Optic Neuritis
Cerebrospinal Fluid
Interleukin-10
Interleukin-17
Interleukin-6
2016

Reduction of total turnaround time through invention of a flexible tube transport system for closed blood sample tubes maintaining analytical quality requirements.

Brandslund, I., Thomsen, C., Bøgh Andersen, I. & Mogensen, N., 2016.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceCommunication

Rhodopsin in Serum – a Biomarker for Diabetic Retinopathy

Rabing Brix Petersen, E., Brandslund, I., Hansen, S. B., Parkner, T. & Christensen, C., 2016.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

2015

HbA1c as the diagnostic criterion for diabetes reduces incidence and prevalence of DM2 by 25% but strongly depending on analytical quality

Brandslund, I., Nielsen, A. A., Hyldtoft Petersen, P., Green, A., Christensen, C. K. & Christensen, H., 2015.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

2014

Alfa-synuclein in cerebrospinal fluid as a possible biomarker for Parkinson disease

Juul Bøgelund Hansen, M., Brandslund, I., Dalsgaard Lund, E., Shorsh, K., Andersen, O. & Vilholm, O. J., 24. Apr 2014. 1 p.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

Disease relapse in ovarian cancer patients detected by HE4 and CA125

Dahl Steffensen, K., Jakobsen, A., Waldstrøm, M., Brandslund, I., Lund, B., Petzold, M. & Mejer Sørensen, S., 2014.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Measurement of Rhodopsin in Serum from 40 Patients with Diabetic Retinopathy.

Brandslund, I., Rabing Brix Petersen, E., Parkner, T., Christensen, C. K. & Hansen, S. B., 2014.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceCommunication

2013

Controls for quantitative total cell free DNA qPCR analyses in plasma

Pallisgaard, N., Fredslund Andersen, R., Spindler, K-L. G., Brandslund, I. & Jakobsen, A., 2013.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Increased alanine aminotransferase levels and associated characteristics among newly diagnosed type 2 diabetes patients: Results from the DD2 study

Mor, A., Thomsen, R. W., Rungby, J., Ulrichsen, S. P., Nielsen, J. S., Stidsen, J., Friborg, S., Brandslund, I., Christiansen6, J. S., Beck-Nielsen, H. & Sørensen, H. T., Apr 2013.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Prevalence of elevated C-reactive protein among newly diagnosed type 2 diabetes patients in Denmark: Results from the population-based DD2 study

Thomsen, R. W., Mor, A., Rungby, J., Ulrichsen, S. P., Nielsen, J. S., Stidsen, J., Friborg, S., Brandslund, I., Christiansen, J. S., Beck-Nielsen, H. & Sørensen, H. T., 18. Jan 2013.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

2010

Clinical Aspects of Hypoxia-inducible Factors in Colorectal Cancer

Havelund, B. M., Spindler, K-L. G., Sørensen, F. B., Brandslund, I. & Jakobsen, A., 2010.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

Clinical Aspects of Hypoxia-inducible Factors in Colorectal Cancer

Havelund, B. M., Spindler, K-L. G., Sørensen, F. B., Brandslund, I. & Jakobsen, A., 2010.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

Clinical aspects of the PDGF and FGF systems in ovarian cancer

Madsen, C. V., Dahl Steffensen, K., Waldstrøm, M., Brandslund, I. & Jakobsen, A., 2010.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

Clinical aspects of vascular endothelial growth factor in breast cancer -Preliminary results of vascular endothelial growth factor single nucleotide polymorphisms analysis

Maae, E., Hugger Rasmussen, E., Dahl Steffensen, K., Sørensen, F. B., Brandslund, I. & Jakobsen, A., 2010.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

Clinical aspects of vascular endothelial growth factor in breast cancer -Preliminary results of vascular endothelial growth factor single nucleotide polymorphisms analysis

Maae, E., Hugger Rasmussen, E., Dahl Steffensen, K., Sørensen, F. B., Brandslund, I. & Jakobsen, A., 2010.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceCommissioned

Clinical aspects of vascular endothelial growth factor in breast cancer -Preliminary results of vascular endothelial growth factor single nucleotide polymorphisms analysis

Maae, E., Hugger Rasmussen, E., Dahl Steffensen, K., Sørensen, F. B., Brandslund, I. & Jakobsen, A., 2010.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

The predictive value of serum VEGF/VEGFR1-2 in bevacizumab treated ovarian cancer patients

Smerdel, M., Dahl Steffensen, K., Waldstrøm, M., Brandslund, I. & Jakobsen, A., 11. Oct 2010.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

2009

Bevacizumab in heavily pre-treated ovarien cancer patients and the predictive value of serum VEGF

Smerdel, M., Dahl Steffensen, K., Waldstrøm, M., Brandslund, I. & Jakobsen, A., 2009.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Prognostic parameters in Dukes´ B colon cancer with the perspective of selection for adjuvant chemotherapy - A population based trial

Kjær-Frifeldt, S., Brandslund, I., Lindebjerg, J., Spindler, K-L. G. & Jakobsen, A., 2009.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

The functional influence of the vascular endothelial growth factor receptor 1 519 C/T single nucleotide polymorphism in colorectal cancer

Hansen, T., Spindler, K-L. G., Olsen, DA., Andersen, RF., Lindebjerg, J., Brandslund, I. & Jakobsen, A., 2009.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

The predictive value of serum VEGF/VEGFRI-2 in bevacizumab treated ovarian cancer patients

Smerdel, M., Dahl Steffensen, K., Waldstrøm, M., Brandslund, I. & Jakobsen, A., 2009.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Open Access
2008

Absence of mutant epidermal growth factor receptor (EGFRVIII) in normal. benign, borderline and malignant ovarian tissue

Dahl Steffensen, K., Waldstrøm, M., Olsen, D. A., Corydon, T., Knudsen, H. J., Jeppesen, U., Brandslund, I. & Jakobsen, A., 2008.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

Multiplex serum tumor markers for the prediction of early relapse in ovarian cancer patients

Dahl Steffensen, K., Waldstrøm, M., Visintin, I., Brandslund, I. & Jakobsen, A., 2008.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER 3 and HER4 in benign and malign ovarian tumors

Dahl Steffensen, K., Waldstrøm, M., Andersen, R. F., Olsen, D. A., Jeppesen, U., Knudsen, H. J., Brandslund, I. & Jakobsen, A., 2008.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

The relationship between vascular endothelial growth factor A and -460 C/T and +405 G/C single nucleotide polymorphisms in colorectal cancer

Hansen, T., Spindler, K-L. G., Lorentzen, K. A., Andersen, R. F., Frischknecht, L., Mortensen, J. P., Brandslund, I. & Jakobsen, A., 2008.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

2007

Absence of Mutant Epidermal Growth Factor Receptor (EGFRvIII) in normal, benign, borderline and malignant ovarian tissue

Dahl Steffensen, K., Waldstrøm, M., Olsen, D. A., Corydon, T., Knudsen, H. J., Jeppesen, U., Brandslund, I. & Jakobsen, A., 2007.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Prediction of response to chemotherapi by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

Dahl Steffensen, K., Waldstrøm, M., Jeppesen, U., Brandslund, I. & Jakobsen, A., 2007.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review